Literature DB >> 18155912

Nutritionally essential fatty acids and biologically indispensable cyclooxygenases.

William L Smith1.   

Abstract

The study of cyclooxygenases (COXs), targets of aspirin and related drugs, is rooted in the discovery of essential fatty acids (EFAs). There are two COXs that convert EFAs, primarily arachidonic acid, to prostaglandins. Each COX is involved with distinct biologies. COX-1 expression is constitutive while COX-2 is inducible. The two COXs might have evolved partly to permit prostaglandin formation at different tissue sites. However, COX-2 is sometimes induced in cells already expressing COX-1, and in these instances, COX-2 functions while COX-1 is latent. This can occur because of unique biochemical properties of COX-2 that enable cells to form prostaglandins when arachidonic acid comprises a small fraction of available fatty acids and the concentrations of peroxides that are necessary for COX to function are low.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155912     DOI: 10.1016/j.tibs.2007.09.013

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  34 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

Review 2.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

Review 3.  Prostaglandin E3 metabolism and cancer.

Authors:  Peiying Yang; Yan Jiang; Susan M Fischer
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

4.  Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors.

Authors:  Zora Djuric; Muhammad Nadeem Aslam; Becky R Simon; Ananda Sen; Yan Jiang; Jianwei Ren; Rena Chan; Tanu Soni; T M Rajendiran; William L Smith; Dean E Brenner
Journal:  J Nutr Biochem       Date:  2017-04-25       Impact factor: 6.048

5.  Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.

Authors:  Gilad Rimon; Ranjinder S Sidhu; D Adam Lauver; Jullia Y Lee; Narayan P Sharma; Chong Yuan; Ryan A Frieler; Raymond C Trievel; Benedict R Lucchesi; William L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

Review 6.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

7.  Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers.

Authors:  Chong Yuan; Ranjinder S Sidhu; Dmitry V Kuklev; Yuji Kado; Masayuki Wada; Inseok Song; William L Smith
Journal:  J Biol Chem       Date:  2009-02-12       Impact factor: 5.157

Review 8.  Polyunsaturated fatty acid derived signaling in reproduction and development: insights from Caenorhabditis elegans and Drosophila melanogaster.

Authors:  Tracy L Vrablik; Jennifer L Watts
Journal:  Mol Reprod Dev       Date:  2013-03-14       Impact factor: 2.609

9.  Contrasting effects of n-3 and n-6 fatty acids on cyclooxygenase-2 in model systems for arthritis.

Authors:  Samantha Hurst; Sarah G Rees; Peter F Randerson; Bruce Caterson; John L Harwood
Journal:  Lipids       Date:  2009-09-26       Impact factor: 1.880

10.  Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression.

Authors:  Mariko Hotta; Rieko Nakata; Michiko Katsukawa; Kazuyuki Hori; Saori Takahashi; Hiroyasu Inoue
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.